Covered recipient · General Payments record
KELSEY ELIZABETH BERRY
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2021–2024
$920.54
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $616.42 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $267.37 | 6 |
| Amgen Inc. | $134.42 | 1 |
| Regeneron Healthcare Solutions, Inc. | $67.92 | 2 |
| GENZYME CORPORATION | $52.78 | 2 |
| GlaxoSmithKline, LLC. | $44.46 | 2 |
| Acerta Pharma LLC | $25.74 | 1 |
| Janssen Pharmaceuticals, Inc | $23.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $114.48 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103316016 | CMS |
| ABBVIE INC. | $31.44 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103316018 | CMS |
| ABBVIE INC. | $28.79 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103316020 | CMS |
| ABBVIE INC. | $32.11 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103316022 | CMS |
| ABBVIE INC. | $28.22 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103316024 | CMS |
| ABBVIE INC. | $32.33 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103316026 | CMS |
| Amgen Inc. | $134.42 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111529338 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.74 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105684197 | CMS |
| GENZYME CORPORATION | $24.69 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139993343 | CMS |
| GENZYME CORPORATION | $28.09 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139993375 | CMS |
| GlaxoSmithKline, LLC. | $21.77 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116546559 | CMS |
| GlaxoSmithKline, LLC. | $22.69 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116266670 | CMS |
| Janssen Pharmaceuticals, Inc | $23.73 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078005158 | CMS |
| Regeneron Healthcare Solutions, Inc. | $31.73 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114009483 | CMS |
| Regeneron Healthcare Solutions, Inc. | $36.19 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114009485 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.